You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française


Cancer Type: Skin, Melanoma      Intent: Palliative
Regimen Category: Evidence-Informed
Exceptional Access Program
    vemURAFenib - For 1st line and 2nd line monotherapy treatment of BRAF V600 mutation-positive unresectable stage IIIC or IV melanoma or metastatic disease according to specific criteria.

Patient Info Sheet

Please see Drugs Used for related Patient Information Sheets. Patient Information Sheets are not yet available for this regimen.

You might also be interested in